Floatz logo

Sovateltide

Stroke Disorder

Pharmazz, Inc.protein_peptidePhase 3Active
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
89/ 100

Competitive context

127 Active assets in the Stroke Disorder cohort.

Asset / SponsorPhaseRating
Aggrenox
Boehringer Ingelheim
Phase 4BBB
INCOBOTULINUMTOXINA
Parc de Salut Mar
Phase 4BBB
ATENOLOL
Northern California Institute of Research and Education
Phase 4BBB
Tenecteplase
Assistance Publique - Hôpitaux de Paris
Phase 4BBB
Dextromethorphan
University of Florida
Phase 4BBB

View all 50 →

Same molecule, other indications

Sovateltide is also rated in:

cerebral infarctionActive
BBB
Indicative · Phase 4
75 / 100
View asset →
brain ischemiaDormant
BB
Indicative · Phase 3
67 / 100
View asset →
dementiaDormant
B
Indicative · Phase 2
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →